
European Commissioner for Health Stella Kyriakides (L) and European Commission President Ursula von der Leyen (Virginia Mayo/AP Images)
'Practically impossible': On the difficulties of introducing new medicines across all 27 EU member states
Timely and equitable access to new medicines across all 27 EU member states has been near the top of every list for the European Commission in describing what it wants to achieve with the overhaul of its 20-year-old pharma legislation.
The only problem is that bridging that gap in access is going to be a Herculean task as currently, Eastern European countries like Latvia, Lithuania and others only see a small fraction of the new drugs that launch across other, wealthier countries like Germany and Austria.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters